HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Frederik L Giesel Selected Research

(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)

2/2015Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
8/2014Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.
9/2012Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
10/2011Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases.
5/2010Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Frederik L Giesel Research Topics

Disease

11Neoplasms (Cancer)
07/2015 - 04/2006
8Prostatic Neoplasms (Prostate Cancer)
01/2016 - 06/2012
3Glioma (Gliomas)
03/2014 - 12/2010
2Meningioma (Meningiomas)
02/2015 - 09/2012
2Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2014 - 10/2011
2Neoplasm Metastasis (Metastasis)
08/2014 - 10/2011
2Brain Neoplasms (Brain Tumor)
03/2014 - 04/2006
1Lung Neoplasms (Lung Cancer)
04/2014
1Astrocytoma (Pilocytic Astrocytoma)
03/2014
1Glioblastoma (Glioblastoma Multiforme)
03/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Adenocarcinoma
06/2012
1Body Weight (Weight, Body)
09/2010
1Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
02/2010
1Ulcer
10/2007
1Aortic Aneurysm (Aneurysm, Aortic)
10/2007
1Leiomyosarcoma
02/2005

Drug/Important Bio-Agent (IBA)

5(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
02/2015 - 05/2010
3human glutamate carboxypeptidase IIIBA
01/2016 - 02/2015
3N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
01/2016 - 02/2015
2Urea (Carbamide)FDA LinkGeneric
01/2016 - 11/2015
2LigandsIBA
02/2015 - 09/2012
2Choline (Choline Chloride)IBA
01/2014 - 12/2010
2Somatostatin Receptors (Somatostatin Receptor)IBA
09/2012 - 10/2011
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2010 - 02/2005
2Adenosine Monophosphate (AMP)IBA
05/2008 - 06/2006
1LutetiumIBA
05/2015
12-(phosphonomethyl)pentanedioic acidIBA
02/2015
1pinacolyl methylphosphonic acidIBA
02/2015
1Peptide Receptors (Peptide Receptor)IBA
08/2014
1Glucose (Dextrose)FDA LinkGeneric
04/2014
1Dihydroxyphenylalanine (Dopa)IBA
03/2014
1fluorodopa F 18IBA
03/2014
1Melanins (Melanin)IBA
01/2014
1BenzamidesIBA
01/2014
1benzamideIBA
01/2014
1Protons (Proton)IBA
06/2012
1PeptidesIBA
10/2011
1Chromogranin AIBA
10/2011
1N-acetylaspartate (N-acetyl aspartate)IBA
12/2010
1ThymidineIBA
12/2010
1gadoteridol (Prohance)FDA Link
09/2010
1gadobenic acid (gadobenate dimeglumine)FDA Link
09/2010
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2010
1Octreotide (Sandostatin)FDA LinkGeneric
05/2010
1Gadolinium DTPA (Magnevist)FDA Link
06/2009
1gadobutrolIBA
06/2009
1Biological Markers (Surrogate Marker)IBA
05/2008
1tranilast (N 5')IBA
10/2007
1Contrast MediaIBA
04/2006
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2006

Therapy/Procedure

5Radiotherapy
01/2016 - 02/2010
1Drug Therapy (Chemotherapy)
07/2015
1Heterologous Transplantation (Xenotransplantation)
02/2015
1Conformal Radiotherapy
12/2013
1Prostatectomy (Retropubic Prostatectomy)
06/2012
1Palliative Care (Palliative Medicine)
05/2010
1Catheters
05/2010